| Product Code: ETC6176088 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Bronchiectasis Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Bronchiectasis Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Bronchiectasis Market - Industry Life Cycle |
3.4 Australia Bronchiectasis Market - Porter's Five Forces |
3.5 Australia Bronchiectasis Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Australia Bronchiectasis Market Revenues & Volume Share, By Severity, 2021 & 2031F |
3.7 Australia Bronchiectasis Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 Australia Bronchiectasis Market Revenues & Volume Share, By Drugs Type, 2021 & 2031F |
3.9 Australia Bronchiectasis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Australia Bronchiectasis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Australia Bronchiectasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bronchiectasis in Australia |
4.2.2 Growing awareness and diagnosis rates of bronchiectasis |
4.2.3 Advancements in bronchiectasis treatment and management options |
4.3 Market Restraints |
4.3.1 High cost of bronchiectasis treatments and medications |
4.3.2 Limited access to specialized healthcare services for bronchiectasis patients |
4.3.3 Lack of standardized guidelines for bronchiectasis management |
5 Australia Bronchiectasis Market Trends |
6 Australia Bronchiectasis Market, By Types |
6.1 Australia Bronchiectasis Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Bronchiectasis Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 Australia Bronchiectasis Market Revenues & Volume, By CF Bronchiectasis, 2021- 2031F |
6.1.4 Australia Bronchiectasis Market Revenues & Volume, By Non-CF Bronchiectasis, 2021- 2031F |
6.2 Australia Bronchiectasis Market, By Severity |
6.2.1 Overview and Analysis |
6.2.2 Australia Bronchiectasis Market Revenues & Volume, By Mild to Moderate, 2021- 2031F |
6.2.3 Australia Bronchiectasis Market Revenues & Volume, By Moderate-to-Severe, 2021- 2031F |
6.3 Australia Bronchiectasis Market, By Type |
6.3.1 Overview and Analysis |
6.3.2 Australia Bronchiectasis Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.3.3 Australia Bronchiectasis Market Revenues & Volume, By Treatment, 2021- 2031F |
6.4 Australia Bronchiectasis Market, By Drugs Type |
6.4.1 Overview and Analysis |
6.4.2 Australia Bronchiectasis Market Revenues & Volume, By Branded, 2021- 2031F |
6.4.3 Australia Bronchiectasis Market Revenues & Volume, By Generics, 2021- 2031F |
6.5 Australia Bronchiectasis Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Australia Bronchiectasis Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 Australia Bronchiectasis Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.5.4 Australia Bronchiectasis Market Revenues & Volume, By Inhalation, 2021- 2031F |
6.6 Australia Bronchiectasis Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 Australia Bronchiectasis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Australia Bronchiectasis Market Revenues & Volume, By Clinics, 2021- 2031F |
6.6.4 Australia Bronchiectasis Market Revenues & Volume, By Home, 2021- 2031F |
6.6.5 Australia Bronchiectasis Market Revenues & Volume, By Healthcare, 2021- 2031F |
7 Australia Bronchiectasis Market Import-Export Trade Statistics |
7.1 Australia Bronchiectasis Market Export to Major Countries |
7.2 Australia Bronchiectasis Market Imports from Major Countries |
8 Australia Bronchiectasis Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis for bronchiectasis patients |
8.2 Number of bronchiectasis patients receiving guideline-recommended treatments |
8.3 Percentage of bronchiectasis patients experiencing disease exacerbations |
8.4 Patient-reported quality of life improvements post-treatment |
8.5 Adoption rate of new bronchiectasis treatment modalities |
9 Australia Bronchiectasis Market - Opportunity Assessment |
9.1 Australia Bronchiectasis Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Australia Bronchiectasis Market Opportunity Assessment, By Severity, 2021 & 2031F |
9.3 Australia Bronchiectasis Market Opportunity Assessment, By Type, 2021 & 2031F |
9.4 Australia Bronchiectasis Market Opportunity Assessment, By Drugs Type, 2021 & 2031F |
9.5 Australia Bronchiectasis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Australia Bronchiectasis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Australia Bronchiectasis Market - Competitive Landscape |
10.1 Australia Bronchiectasis Market Revenue Share, By Companies, 2024 |
10.2 Australia Bronchiectasis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |